Articles related to ‘FDA media releases’
-
Degarelix (Firmagon) for prostate cancer: now approved by FDA
-
FDA approves gadofosveset trisodium (Vasovist) as first contrast agent for magnetic resonance angiography (MRA)
-
FDA approves imatinib (Gleevec) for a new indication: GIST tumors.
-
FDA approves plerixafor (Mozobil) for use in multiple myeloma and non Hodgkin’s lymphomas
-
Antiepileptic drugs (AEDs): FDA requires warnings about suicidal thoughts and behaviors (suicidality)
-
An FDA advisory panel voted to ban formoterol (Serevent) and salmeterol (Foradil)
-
FDA: statins do not increase the risk of amyotrophic lateral sclerosis (ALS)
-
FDA video on Ephedrine and Epinephrine: how to prevent mistakes in their administration.
-
Phenytoin and fosphenytoin linked to Stevens Johnson syndrome and toxic epidermal necrolysis
-
Myths and facts about generic drugs: FDA presentation
-
Tapentadol approved by FDA as treatment for moderate to severe pain
-
Atrial fibrillation and bisphosphonates: FDA Medwatch update
-
Rufinamide approved as adjunctive for Lennox Gastaut syndrome
